← All diseases
Lungs and airways
Pulmonary fibrosis (IPF)
Would you like to receive a message when there is new research on Idiopathic Pulmonary Fibrosis (IPF)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was researched — and you'll receive a notification as soon as there is new research on Pulmonary Fibrosis (IPF). View what Premium costs.
Publications and studies (1939)
- Emergence of Disease-relevant Aberrant Epithelial Cell States in Human Alveolar Organoids. (2026/07/22) ♡
- Selective phosphodiesterase 4B inhibition in fibrotic lung disease: a scoping review of vascular-immune mechanisms and extrapulmonary implications. (2026/07/22) ♡
- Cell-Specific Modulation of the Aryl Hydrocarbon Receptor by Kynurenine in Pulmonary Fibrosis Requires Microenvironmental Crosstalk. (2026/07/22) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Biological activity assessment of isolated flavonoid from Cordia sinensis: in vitro and in silico evaluation against idiopathic pulmonary fibrosis. (2026/07/21) ♡
- Trilobatin ameliorates pulmonary fibrosis by directly targeting MEK1 to antagonize TGF-β-driven epithelial-mesenchymal transition. (2026/07/21) ♡
- MPT0E028, a pan-HDAC inhibitor, ameliorates bleomycin-induced pulmonary fibrosis by promoting AT2-to-AT1 differentiation through the ATM/AMPK/FoxO1 pathway. (2026/07/21) ♡
- Incidence and prevalence of interstitial lung diseases in Norway: analysis of the national Norwegian patient registry. (2026/07/21) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current Clinical Perspectives of Biomarkers in Respiratory Diseases: A Narrative Review. (2026/07/21) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Krueppel-like factors transcriptionally regulate idiopathic pulmonary fibrosis. (2026/07/20) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Clearing the haze around familial interstitial lung abnormalities. (2026/07/20) ♡
- Development and internal validation of a nomogram to predict pulmonary hypertension in fibrosing interstitial lung diseases. (2026/07/20) ♡
- SM17, an anti-interleukin-17 receptor B antibody, ameliorates pathogenesis of chronic rhinosinusitis with nasal polyps and idiopathic pulmonary fibrosis via Th2/Th17 dual modulation. (2026/07/20) ♡
- Lung cancer in interstitial lung disease: a matched case-control and cohort analysis. (2026/07/20) ♡
- MICA-129Met/Val as a therapeutic compass in idiopathic pulmonary fibrosis: prognosis and antifibrotic benefit. (2026/07/20) ♡
- A CT-based score for predicting histopathological usual interstitial pneumonia features and predicting disease progression in smokers with fibrotic idiopathic interstitial pneumonia. (2026/07/18) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Gut-Lung Microbiome Axis in Alveolar Stem Cell Regeneration and Lung Repair. (2026/07/18) ♡
- Alveolar Epithelial Cell Loss of the Mitochondrial Regulator TFAM Drives Progressive Lung Fibrosis. (2026/07/18) ♡
- Vitronectin metabolically programs profibrotic macrophages in 3D cultures and idiopathic pulmonary fibrosis. (2026/07/17) ♡
- Early rehabilitation after acute exacerbation of idiopathic pulmonary fibrosis: A nationwide observational study. (2026/07/17) ♡
- Accumulation of mucosal and lymphoid hypo-functional granzyme K producing CD8(+) effector memory T cells in idiopathic pulmonary fibrosis. (2026/07/17) ♡
- Distinct cytokine and chemokine alterations in bronchoalveolar fluid from patients with systemic juvenile idiopathic arthritis associated lung disease (SJIA-LD). (2026/07/17) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. The Effect of Food on the Pharmacokinetics and Gastrointestinal Tolerability of Bersiporocin, a Novel Oral Prolyl-tRNA-Synthetase Inhibitor. (2026/07/17) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Breaking barriers in pulmonary health of patients with metabolic diseases: senolytics and beyond. (2026/07/17) ♡
- Plasma proteomics and machine learning deliver non-invasive distinction between fibrotic hypersensitivity pneumonitis and idiopathic pulmonary fibrosis. (2026/07/17) ♡
- Gradually, then suddenly: Deconvoluting the natural history of idiopathic pulmonary fibrosis. (2026/07/16) ♡
- Progressive pulmonary fibrosis criteria predict mortality in treated idiopathic pulmonary fibrosis: a prospective cohort study. (2026/07/16) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Feasibility and acceptability of whole-body electromyostimulation in pulmonary rehabilitation for patients with chronic respiratory disease: a pilot study protocol. (2026/07/16) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Precision Modulation of the PDE4 Pathway: The Emerging Role of Nerandomilast in Pulmonary Fibrosis. (2026/07/16) ♡
- Beyond Diffusion Capacity: Continuous Exercise Oximetry Reveals Phenotype-Related Cardiopulmonary Signals in Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis-A eurILDreg Pilot Study. (2026/07/16) ♡
- Evaluation of the prognostic value of visual and quantitative CT analysis in myositis-associated interstitial lung disease. (2026/07/15) ♡
- Translational prioritization of genetically supported candidate targets and pharmacological annotations for chronic lung diseases: a single-cell eQTL-guided multi-cohort study. (2026/07/15) ♡
- Biomarker profiles in idiopathic and progressive pulmonary fibrosis after LPA(1) antagonism: exploratory analysis from a phase 2 trial of admilparant. (2026/07/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Next-Generation Sequencing in Pulmonary Fibrosis: Translational Promise and Current Clinical Limitations. (2026/07/15) ♡
- Smoking-Related Clinical and Molecular Abnormalities in Idiopathic Pulmonary Fibrosis-Associated Pulmonary Hypertension. (2026/07/14) ♡
- Large-scale automated detection reveals pervasive sex imbalance in biomedical research. (2026/07/14) ♡
- Senescent Alveolospheres: A Preliminary 3D Model for Exploring Epithelial Senescence and Pro-Fibrotic Signaling. (2026/07/10) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Explosive multi-site metastasis temporally associated with acute exacerbation of idiopathic pulmonary fibrosis in a patient with surgically resected lung squamous cell carcinoma: a case report. (2026/07/07) ♡
- Changing Mortality Patterns in Idiopathic Pulmonary Fibrosis in Spain: Sex-Specific and Regional Joinpoint Trends, 1999-2021. (2026/07/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Diagnostic and Prognostic Value of Serum Surfactant Protein D in Interstitial Lung Disease: A Systematic Review. (2026/07/03) ♡
- S100A8(+)S100A9(+) transitional macrophages are associated with pulmonary fibrosis progression by integrating immunometabolism and fibrogenic crosstalk. (2026/07/02) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Pulmonary Complications in Cirrhosis: Current Concepts and Clinical Perspectives. (2026/07/02) ♡
- Admission-Based Machine-Learning Models for Predicting Mechanical Ventilation and Mortality in Fibrotic Interstitial Lung Disease: A Multicenter Cohort Study with External Validation. (2026/07/02) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Spontaneous pneumothorax in a dog with interstitial pulmonary fibrosis and ruptured bullae. (2026/07/01) ♡
- Histologic patterns of chronic interstitial lung disease in dogs. (2026/07/01) ♡
- Altered AP-1, RUNX, and EGR chromatin dynamics drive human fibrotic lung disease. (2026/07/01) ♡
- A Nomogram Model for Early Mortality Risk Stratification in Elderly Patients with Idiopathic Pulmonary Fibrosis: An Integrative Analysis of Serum Biomarkers and Pulmonary Function Parameters. (2026/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Statement of the Austrian Society of Pneumology expert group for interstitial lung diseases and orphan diseases on the 2025 update of the international multidisciplinary classification of interstitial pneumonias]. (2026/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Respiratory Epithelial Barrier as an Immunopharmacological Rheostat: From Homeostatic Sentinel to Therapeutic Target in Chronic Lung Disease. (2026/07/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Natural therapeutics and traditional formulas targeting macrophage polarization in the fibrotic niche of idiopathic pulmonary fibrosis. (2026/06/30) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Shengxian decoction mitigate bleomycin-induced pulmonary fibrosis in mice via MerTK mediated macrophage efferocytosis. (2026/06/28) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.